JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Management of cystic hygromas: 30 year experience.

Cystic hygroma is a rare congenital malformation of the lymphatic system. In most centers, surgical excision is considered to be the optimal mode of treatment. Spontaneous resolution of cystic hygroma was briefly described in the literature with unsatisfactory results. Between 1970 and 2003, 14 patients were diagnosed to have cystic hygroma (13 cervical and 1 axillary). A retrospective review was performed. All patients were treated successfully with aspiration alone with a mean follow-up time of 5.75 years. Three patients needed multiple aspirations (average 1.66) with complete resolution. Complications were limited to one case of infection treated with antibiotics with no residual problems. Conservative management of cystic hygroma is a reliable mode of treatment with a low complication rate. Intralesional sclerosant injection and surgery should be reserved for other forms of lymphatic malformations.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app